GSK Jan 2026 33.000 put
| Previous close | 0.8300 |
| Open | 0.8500 |
| Bid | 0.0000 |
| Ask | 1.1500 |
| Strike | 33.00 |
| Expiry date | 2026-01-16 |
| Day's range | 0.8300 - 0.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 44 |
BloombergModerna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t Track‘Seriously Underwater’ Home Mortgages Tick Up Across th
Fool.co.ukNew to the stock market? Here are 2 of the best shares to consider buying
Starting out in the stock market can be confusing. Here, this Fool explains his strategy and picks out two shares he'd consider buying. The post New to the stock market? Here are 2 of the best shares to consider buying appeared first on The Motley Fool UK.
Simply Wall St.GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
